Tepotinib
13 interactions 2 explained in plain EnglishTepotinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the body in adults. Tepotinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the… Read the full Tepotinib drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Contraindicated
Tepotinib Colchicine Colcrys Explained Increased colchicine exposure and an increased risk of colchicine toxicity DetailsMajor
Tepotinib Relugolix Orgovyx Explained Increased relugolix exposure Details Tepotinib Cyclosporine Injection Atopica Increased P-gp substrate exposure and an increased risk of P-gp substrate-related adverse effects Details Tepotinib Cyclosporine Ophthalmic Cequa Increased P-gp substrate exposure and an increased risk of P-gp substrate-related adverse effects Details Tepotinib Dabigatran Pradaxa® Increased dabigatran exposure and an increased risk of bleeding Details Tepotinib Dabigatran Etexilate Increased dabigatran exposure and an increased risk of bleeding Details Tepotinib Digoxin Cardoxin® Increased P-gp substrate exposure and an increased risk of P-gp substrate-related adverse effects Details Tepotinib Doxorubicin Adriamycin Increased DOXOrubicin exposure and an increased risk of DOXOrubicin-related adverse reactions Details Tepotinib Everolimus Afinitor Increased P-gp substrate exposure and an increased risk of P-gp substrate-related adverse effects Details Tepotinib Lefamulin Xenleta Increased lefamulin exposure and an increased risk of lefamulin-related adverse reactions Details Tepotinib Loperamide Diamode Increased loperamide exposure and an increased risk of loperamide-related adverse effects Details Tepotinib Morphine Injection Astramorph® PF Increased morphine exposure and an increased risk of morphine-related adverse effects (hypotension, respiratory depression, profou... DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist